Back grey_arrow_rt.gif
 
Archived NATAP Articles from January 2003
 
null.gif
 
 
  1. Influence of Coinfection with Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy (1/31/03)

  2.  
  3. CDC Hepatitis C Coordinators Conference: brief selected highlights. Remember the Alamo. (1/30/03)

  4.  
  5. Prevention and Control of Infections with Hepatitis Viruses in Correctional Settings (1/27/03)

  6.  
  7. Brief Report: Limited Evolution of HIV Antiretroviral Drug Resistance-Associated Mutations During the Performance of Drug Resistance Testing - written by Sean Emery (1/27/03)

  8.  
  9. ALT & Biopsy Predict Outcome (1/27/03)

  10.  
  11. Fatty Liver Disease, ALT, & Overweight (1/27/03)

  12.  
  13. Delavirdine Generics Deal in Works (1/24/03)

  14.  
  15. Knowledge of Genotypic Resistance Mutations Among Providers of Care to Patients with Human Immunodeficiency Virus (1/24/03)

  16.  
  17. Hepatitis C Virus and Human Immunodeficiency Virus Coinfection in an Urban Population: Low Eligibility for Interferon Treatment (1/24/03)

  18.  
  19. Pharmacia Nears Deal to Sell Cheaper Version of AIDS Drug to Undeveloped Nations - By SCOTT HENSLEY Staff Reporter of THE WALL STREET JOURNAL (1/24/03)

  20.  
  21. Serum Retinol Levels and the Risk of Fracture (1/23/03)

  22.  
  23. Differentiating hyperlipidaemia associated with antiretroviral therapy (1/21/03)

  24.  
  25. GLAXOSMITHKLINE AND ONO TO COLLABORATE ON DEVELOPMENT AND COMMERCIALISATION OF ONO-4128, A NEW CCR5 ANTAGONIST FOR HIV (1/21/03)

  26.  
  27. Does HIV Accelerate HCV Progression? (1/21/03)

  28.  
  29. The burden of hepatitis C in the United States (1/21/03)

  30.  
  31. Estimating future hepatitis C morbidity, mortality, and costs in the United States (1/21/03)

  32.  
  33. Clinical & Cost Implications of Early Viral Response Treatment Management Algorithms & Adherence During PegInterferon and Ribavirin Therapy (1/21/03)

  34.  
  35. The Clinical Spectrum of Hepatitis C Virus in HIV Coinfection (1/17/03)

  36.  
  37. Health-Related Quality of Life After 1 Year of Highly Active Antiretroviral Therapy (1/17/03)

  38.  
  39. Interleukin-2 Increases CD4+ Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s (1/17/03)

  40.  
  41. Tipranavir Phase III Studies and Compassionate Access Program (1/16/03)

  42.  
  43. Tenofovir Resistance in Treatment-Naïve: study 903 tenofovir vs d4T (1/14/03)

  44.  
  45. The Secret War on Condoms - By NICHOLAS D. KRISTOF, NY Times, Jan 10, 2003 (1/14/03)

  46.  
  47. Multiple Characteristics of HAART Affect Adherence Described (1/14/03)

  48.  
  49. Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors - Ronit Ben-Romano a; Assaf Rudich d; Dora Torok d; Sharon Vanounou a; Klaris Riesenberg b; Francisc Schlaeffer b; Amira Klip d; Nava Bashan a,c (1/14/03)

  50.  
  51. ROCHE ANNOUNCES PRICE ON RIBAVIRIN (1/14/03)

  52.  
  53. Roche Dramatically Reduces Cost of Combination Therapy for Millions of Americans Chronically Infected with Hepatitis C - Press Release from Roche (1/14/03)

  54.  
  55. Hepatitis C treatment may cost N.J. millions - By Mark Fazlollah and Jennifer Lin Philadelpha Inquirer, Jan 12 2003 (1/14/03)

  56.  
  57. Most States Are Cutting Medicaid Benefits, Study Says - By THE ASSOCIATED PRESS (1/14/03)

  58.  
  59. Dosing Kaletra With Efavirenz (1/14/03)

  60.  
  61. Pharmacokinetic-Pharmacodynamic Analysis of Lopinavir-Ritonavir in Combination with Efavirenz and Two Nucleoside Reverse Transcriptase Inhibitors in Extensively Pretreated Human Immunodeficiency Virus-Infected Patients (1/10/03)

  62.  
  63. New HCV and HBV Drugs - PRNewswire (1/9/03)

  64.  
  65. Liver Transplantation in HIV (1/9/03)

  66.  
  67. Liver Transplantation Update for HIV & IVDUs (1/8/03)

  68.  
  69. Hepatology Highlights - Hepatology, January 2003, Volume 37, Number 1 Harvey J. Alter, Viral Hepatitis Editor - (1/8/03)

  70.  
  71. Is HCV Curable? - Reported by Jules Levin - (1/8/03)

  72.  
  73. Food Combo as Good as Cholesterol Drugs - By Daniel DeNoon Source: WebMD Medical News - (1/7/03)

  74.  
  75. Interactions between recreational drugs and antiretroviral agents - Antoniou T, Tseng AL. HIV Program/Inner City Health, St. Michael's Hospital, Toronto, Ontario, Canada. PDF FORMAT - (1/7/03)

  76.  
  77. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals - (1/7/03)

  78.  
  79. Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors - (1/7/03)

  80.  
  81. Efficacy of Efavirenz in Different Racial Groups - (1/3/03)

  82.  
  83. CDC SMALLPOX FACT SHEET - (1/3/03)

  84.  
  85. HCV Protease Inhibitors: Vertex VX-950 clinical trial in 2003 - (1/3/03)

  86.  
  87. FDA Approves d4T Once Daily, Extended Release Formulation - (1/3/03)

  88.  
  89. Does HCV Replicate Outside The Liver and It's Significance? - (1/3/03)

  90.  
  91. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B - (1/3/03)

  92.  
  93. Hepatitis C Protease Inhibitors - (1/3/03)

  94.